Symbols / IVF
IVF Chart
About
INVO Fertility, Inc., a healthcare services company, focuses on the fertility marketplace that provides assisted reproductive technology care to patients. It operates through Fertility Clinic Services; INVOcell Device; and Therapeutics segments. The company offers INVOcell Device, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. It also operates fertility clinics, including INVO Centers. In addition, the company develops NY-303, a GPC3 x NKp46 bifunctional antibody that is in Phase i/ii a monotherapy trial for the treatment of hepatocellular carcinoma; and NY-500, an AI-optimized bifunctional antibody. The company was formerly known as NAYA Biosciences, Inc. and changed its name to INVO Fertility, Inc. in April 2025. INVO Fertility, Inc. was founded in 2007 and is based in Sarasota, Florida.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Medical Devices | Market Cap | 6.95M |
| Enterprise Value | 14.64M | Income | -11.22M | Sales | 6.94M |
| Book/sh | -4.47 | Cash/sh | 0.19 | Dividend Yield | — |
| Payout | 0.00% | Employees | 33 | IPO | — |
| P/E | — | Forward P/E | -0.22 | PEG | — |
| P/S | 1.00 | P/B | -0.22 | P/C | — |
| EV/EBITDA | -2.06 | EV/Sales | 2.11 | Quick Ratio | 0.07 |
| Current Ratio | 0.12 | Debt/Eq | 72.39 | LT Debt/Eq | — |
| EPS (ttm) | -294.88 | EPS next Y | -4.64 | EPS Growth | — |
| Revenue Growth | 22.60% | Earnings | 2025-04-30 09:00 | ROA | -48.36% |
| ROE | — | ROIC | — | Gross Margin | 39.17% |
| Oper. Margin | -93.08% | Profit Margin | 0.00% | Shs Outstand | 6.96M |
| Shs Float | 1.73M | Short Float | 2.34% | Short Ratio | 0.02 |
| Short Interest | — | 52W High | 120.96 | 52W Low | 0.71 |
| Beta | — | Avg Volume | 7.52M | Volume | 508.99K |
| Target Price | $4.00 | Recom | None | Prev Close | $0.94 |
| Price | $1.00 | Change | 6.23% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
$4.00
Mean price target
2. Current target
$1.00
Latest analyst target
3. DCF / Fair value
$2.46
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$1.00
Low
$4.00
High
$4.00
Mean
$4.00
News
RSS: Latest IVF news- INVO Fertility Closes Family Beginnings Acquisition for $760,000, Part Cash and Preferred Stock - TradingView ue, 24 Feb 2026 14
- Top-rated Indiana fertility clinic sold for $760K to INVO Fertility - Stock Titan hu, 19 Feb 2026 13
- INVO Fertility, Inc. Announces Strategic Outlook for Growth and Strengthened Financial Position - Quiver Quantitative Wed, 04 Feb 2026 08
- INVO Fertility (IVF) Price Target Increased by 700.00% to 146.88 - Nasdaq Fri, 05 Dec 2025 08
- Why Is INVO Fertility Stock (IVF) Up Today? - TipRanks ue, 20 Jan 2026 08
- A Little-Known Fertility Stock Soared 350% — Here’s What Traders Are Watching - Stocktwits ue, 20 Jan 2026 13
- This Little-Known Fertility Stock Is Up 215% in the Past 5 Days. Should You Chase the Mysterious Penny Stock Rally Here? - Barchart.com ue, 20 Jan 2026 08
- INVO Fertility stock soars after planned acquisition of Indiana clinic - Investing.com Fri, 28 Nov 2025 08
- IVF’s Stock Experiences Drastic Fluctuations Amid Volatile Market Trends - StocksToTrade Sun, 18 Jan 2026 08
- INVO Fertility (NASDAQ: IVF) sets $4.0M private placement at $1.69 per unit - Stock Titan ue, 02 Dec 2025 08
- INVO Fertility Soars Over 300% - Nasdaq ue, 20 Jan 2026 08
- INVO Fertility, Inc. Announces 1-for-8 Reverse Stock Split Effective November 28, 2025 | IVF Stock News - Quiver Quantitative ue, 25 Nov 2025 08
- INVO Fertility (NASDAQ: IVF) Plans 1-for-8 Reverse Stock Split on Nasdaq Capital Market - Stock Titan ue, 25 Nov 2025 08
- INVO Fertility To Implement Yet Another Reverse Stock Split This Year - Nasdaq Wed, 26 Nov 2025 08
- $IVF stock is up 61% today. Here's what we see in our data. - Quiver Quantitative ue, 27 Jan 2026 08
Insider Transactions
| Date | Shares | Value | Url | Text | Insider | Position | Transaction | Start Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|
| 0 | 4 | 6 | — | Sale at price 1.52 per share. | SZOT MATTHEW K | Director | — | 2025-12-03 00:00:00 | D |
Financials
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| TaxEffectOfUnusualItems | -1.14K | -53.23K | -727.23 | 42.01K |
| TaxRateForCalcs | 0.00 | 0.21 | 0.21 | 0.27 |
| NormalizedEBITDA | -6.69M | -6.63M | -10.75M | -5.37M |
| TotalUnusualItems | -457.60K | -253.49K | -3.46K | 155.59K |
| TotalUnusualItemsExcludingGoodwill | -457.60K | -253.49K | -3.46K | 155.59K |
| NetIncomeFromContinuingOperationNetMinorityInterest | -9.10M | -8.03M | -10.89M | -6.65M |
| ReconciledDepreciation | 919.60K | 200.89K | 77.30K | 166.08K |
| ReconciledCostOfRevenue | 3.66M | 1.93M | 850.77K | 145.05K |
| EBITDA | -7.14M | -6.88M | -10.75M | -5.22M |
| EBIT | -8.06M | -7.08M | -10.83M | -5.38M |
| NetInterestIncome | -1.06M | -925.91K | -59.14K | -1.26M |
| InterestExpense | 1.06M | 925.91K | 59.45K | 1.27M |
| InterestIncome | 0.00 | 308.00 | 3.66K | |
| NormalizedIncome | -8.64M | -7.83M | -10.89M | -6.77M |
| NetIncomeFromContinuingAndDiscontinuedOperation | -9.10M | -8.03M | -10.89M | -6.65M |
| TotalExpenses | 14.15M | 9.79M | 11.45M | 9.38M |
| TotalOperatingIncomeAsReported | -8.13M | -6.77M | -10.63M | -5.22M |
| DilutedAverageShares | 12.90K | 4.97K | 2.10K | 1.84K |
| BasicAverageShares | 12.90K | 4.97K | 2.10K | 1.84K |
| DilutedEPS | -724.56 | -1.62K | -5.18K | -3.63K |
| BasicEPS | -724.56 | -1.62K | -5.18K | -3.63K |
| DilutedNIAvailtoComStockholders | -9.35M | -8.03M | -10.89M | -6.65M |
| NetIncomeCommonStockholders | -9.35M | -8.03M | -10.89M | -6.65M |
| OtherunderPreferredStockDividend | 250.63K | 0.00 | ||
| NetIncome | -9.10M | -8.03M | -10.89M | -6.65M |
| NetIncomeIncludingNoncontrollingInterests | -9.10M | -8.03M | -10.89M | -6.65M |
| NetIncomeContinuousOperations | -9.10M | -8.03M | -10.89M | -6.65M |
| TaxProvision | -22.91K | 27.79K | 2.87K | 4.76K |
| PretaxIncome | -9.12M | -8.01M | -10.89M | -6.65M |
| OtherIncomeExpense | -448.56K | -313.76K | -204.02K | -171.95K |
| SpecialIncomeCharges | -457.60K | -253.07K | 0.00 | 159.13K |
| GainOnSaleOfPPE | -511.66K | 0.00 | ||
| OtherSpecialCharges | -54.06K | 163.28K | -159.13K | |
| WriteOff | 0.00 | 89.79K | 0.00 | |
| EarningsFromEquityInterest | 9.04K | -60.27K | -200.56K | -327.54K |
| GainOnSaleOfSecurity | -420.00 | -3.46K | -3.53K | |
| NetNonOperatingInterestIncomeExpense | -1.06M | -925.91K | -59.14K | -1.26M |
| InterestExpenseNonOperating | 1.06M | 925.91K | 59.45K | 1.27M |
| InterestIncomeNonOperating | 0.00 | 308.00 | 3.66K | |
| OperatingIncome | -7.61M | -6.77M | -10.63M | -5.22M |
| OperatingExpense | 10.49M | 7.85M | 10.60M | 9.23M |
| DepreciationAmortizationDepletionIncomeStatement | 919.60K | 200.89K | 77.30K | |
| DepreciationAndAmortizationInIncomeStatement | 919.60K | 200.89K | 77.30K | |
| ResearchAndDevelopment | 489.66K | 165.94K | 544.04K | 216.43K |
| SellingGeneralAndAdministration | 9.08M | 7.49M | 9.98M | 9.02M |
| GrossProfit | 2.87M | 1.09M | -28.57K | 4.02M |
| CostOfRevenue | 3.66M | 1.93M | 850.77K | 145.05K |
| TotalRevenue | 6.53M | 3.02M | 822.20K | 4.16M |
| OperatingRevenue | 6.53M | 3.02M | 822.20K | 4.16M |
| Line Item | 2023-12-31 | |||
|---|---|---|---|---|
| TreasurySharesNumber | 0.00 | |||
| OrdinarySharesNumber | 124.34K | 69.24K | 16.91K | 16.57K |
| ShareIssued | 124.34K | 69.24K | 16.91K | 16.57K |
| NetDebt | 6.73M | 2.53M | 672.51K | |
| TotalDebt | 9.90M | 6.30M | 2.27M | 2.12M |
| TangibleBookValue | -59.27M | -15.08M | -977.61K | 7.18M |
| InvestedCapital | -10.16M | -2.34M | -214.97K | 7.31M |
| WorkingCapital | -16.61M | -6.74M | -2.72M | 5.05M |
| NetTangibleAssets | -28.89M | -9.08M | -977.61K | 7.18M |
| CapitalLeaseObligations | 2.43M | 3.54M | 1.51M | 2.12M |
| CommonStockEquity | -17.63M | -5.11M | -977.61K | 7.31M |
| PreferredStockEquity | 30.38M | 6.00M | ||
| TotalCapitalization | 13.88M | 2.15M | -977.61K | 7.31M |
| TotalEquityGrossMinorityInterest | 12.75M | 892.60K | -977.61K | 7.31M |
| StockholdersEquity | 12.75M | 892.60K | -977.61K | 7.31M |
| RetainedEarnings | -67.16M | -57.82M | -49.78M | -38.89M |
| AdditionalPaidInCapital | 49.54M | 52.71M | 48.81M | 46.20M |
| CapitalStock | 30.38M | 6.00M | 61.00 | 1.19K |
| CommonStock | 37.00 | 20.00 | 61.00 | 1.19K |
| PreferredStock | 30.38M | 6.00M | 0.00 | |
| TotalLiabilitiesNetMinorityInterest | 33.70M | 17.61M | 4.69M | 3.16M |
| TotalNonCurrentLiabilitiesNetMinorityInterest | 15.78M | 9.61M | 1.35M | 1.90M |
| OtherNonCurrentLiabilities | 229.00 | |||
| PreferredSecuritiesOutsideStockEquity | 7.46M | 0.00 | ||
| TradeandOtherPayablesNonCurrent | 5.00M | 5.00M | 0.00 | |
| NonCurrentDeferredLiabilities | 0.00 | 1.95K | 1.14K | |
| NonCurrentDeferredRevenue | 0.00 | |||
| NonCurrentDeferredTaxesLiabilities | 0.00 | 1.95K | 1.14K | |
| LongTermDebtAndCapitalLeaseObligation | 3.32M | 4.61M | 1.35M | 1.90M |
| LongTermCapitalLeaseObligation | 2.19M | 3.36M | 1.35M | 1.90M |
| LongTermDebt | 1.13M | 1.25M | ||
| CurrentLiabilities | 17.93M | 8.00M | 3.34M | 1.25M |
| OtherCurrentLiabilities | 410.00K | 350.00K | ||
| CurrentDeferredLiabilities | 602.36K | 408.77K | 119.88K | 5.90K |
| CurrentDeferredRevenue | 602.36K | 408.77K | 119.88K | 5.90K |
| CurrentDebtAndCapitalLeaseObligation | 6.58M | 1.69M | 922.83K | 221.99K |
| CurrentCapitalLeaseObligation | 239.12K | 181.57K | 160.19K | 221.99K |
| CurrentDebt | 6.34M | 1.51M | 762.64K | |
| OtherCurrentBorrowings | 5.46M | 629.92K | 100.00K | |
| CurrentNotesPayable | 880.00K | 880.00K | 662.64K | 0.00 |
| PensionandOtherPostRetirementBenefitPlansCurrent | 2.12M | 722.25K | 946.26K | 581.69K |
| PayablesAndAccruedExpenses | 8.21M | 4.83M | 1.35M | 443.42K |
| Payables | 8.21M | 4.83M | 1.35M | 443.42K |
| OtherPayable | 2.50M | 2.50M | ||
| TotalTaxPayable | 0.00 | |||
| IncomeTaxPayable | 0.00 | |||
| AccountsPayable | 5.71M | 2.33M | 1.35M | 443.42K |
| TotalAssets | 46.45M | 18.51M | 3.71M | 10.47M |
| TotalNonCurrentAssets | 45.13M | 17.25M | 3.09M | 4.16M |
| InvestmentsAndAdvances | 740.76K | 3.09M | 1.24M | 1.49M |
| LongTermEquityInvestment | 740.76K | 3.09M | 1.24M | 1.49M |
| InvestmentsinJointVenturesatCost | 740.76K | 916.25K | 1.24M | 1.49M |
| InvestmentsinSubsidiariesatCost | 0.00 | 2.17M | 0.00 | |
| GoodwillAndOtherIntangibleAssets | 41.64M | 9.97M | 0.00 | 132.09K |
| OtherIntangibleAssets | 18.10M | 4.09M | 132.09K | |
| Goodwill | 23.54M | 5.88M | 0.00 | |
| NetPPE | 2.75M | 4.19M | 1.85M | 2.54M |
| AccumulatedDepreciation | -335.69K | -233.59K | -153.27K | -78.21K |
| GrossPPE | 3.09M | 4.42M | 2.00M | 2.62M |
| Leases | 96.82K | 538.15K | 96.82K | 96.82K |
| OtherProperties | 2.90M | 3.80M | 1.83M | 2.44M |
| MachineryFurnitureEquipment | 89.90K | 85.40K | 77.60K | 74.89K |
| Properties | 0.00 | 0.00 | 0.00 | 0.00 |
| CurrentAssets | 1.32M | 1.26M | 621.09K | 6.31M |
| OtherCurrentAssets | 182.29K | 622.29K | 190.20K | 282.75K |
| PrepaidAssets | 282.75K | |||
| Inventory | 219.76K | 264.51K | 263.60K | 287.77K |
| FinishedGoods | 166.23K | 211.03K | 194.88K | 220.17K |
| WorkInProcess | 0.00 | |||
| RawMaterials | 53.54K | 53.48K | 68.72K | 67.61K |
| Receivables | 174.88K | 140.55K | 77.15K | 50.47K |
| AccountsReceivable | 174.88K | 140.55K | 77.15K | 50.47K |
| CashCashEquivalentsAndShortTermInvestments | 741.40K | 232.42K | 90.14K | 5.68M |
| CashAndCashEquivalents | 741.40K | 232.42K | 90.14K | 5.68M |
| CashFinancial | 741.40K | 232.42K | 90.14K | 5.68M |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| FreeCashFlow | -3.16M | -5.20M | -6.62M | -6.48M |
| RepaymentOfDebt | -934.42K | -1.50M | 0.00 | -250.00K |
| IssuanceOfDebt | 1.34M | 3.16M | 800.00K | 0.00 |
| IssuanceOfCapitalStock | 1.81M | 5.70M | 289.80K | 3.65M |
| CapitalExpenditure | -183.70K | -444.72K | -12.73K | -454.65K |
| InterestPaidSupplementalData | 214.74K | 9.64K | 0.00 | 52.60K |
| IncomeTaxPaidSupplementalData | 0.00 | 0.00 | 800.00 | 3.31K |
| EndCashPosition | 741.40K | 232.42K | 90.14K | 5.68M |
| BeginningCashPosition | 232.42K | 90.14K | 5.68M | 10.10M |
| ChangesInCash | 508.97K | 142.29K | -5.59M | -4.41M |
| FinancingCashFlow | 3.12M | 7.39M | 1.09M | 3.77M |
| CashFlowFromContinuingFinancingActivities | 3.12M | 7.39M | 1.09M | 3.77M |
| ProceedsFromStockOptionExercised | 900.61K | 25.43K | 0.00 | 369.84K |
| NetPreferredStockIssuance | 1.64M | 0.00 | ||
| PreferredStockIssuance | 1.64M | 0.00 | ||
| NetCommonStockIssuance | 165.13K | 5.70M | 289.80K | 3.65M |
| CommonStockIssuance | 165.13K | 5.70M | 289.80K | 3.65M |
| NetIssuancePaymentsOfDebt | 409.83K | 1.66M | 800.00K | -250.00K |
| NetShortTermDebtIssuance | 0.00 | 100.00K | 800.00K | -250.00K |
| ShortTermDebtPayments | 0.00 | -250.00K | ||
| ShortTermDebtIssuance | 0.00 | 100.00K | 800.00K | 0.00 |
| NetLongTermDebtIssuance | 409.83K | 1.66M | 800.00K | -250.00K |
| LongTermDebtPayments | -934.42K | -1.50M | 0.00 | -250.00K |
| LongTermDebtIssuance | 1.34M | 3.16M | 800.00K | 0.00 |
| InvestingCashFlow | 363.89K | -2.49M | -81.22K | -2.15M |
| CashFlowFromContinuingInvestingActivities | 363.89K | -2.49M | -81.22K | -2.15M |
| NetBusinessPurchaseAndSale | 472.01K | -2.05M | -68.49K | -1.70M |
| SaleOfBusiness | 472.01K | 0.00 | ||
| PurchaseOfBusiness | 0.00 | -2.05M | -68.49K | -1.70M |
| NetIntangiblesPurchaseAndSale | 0.00 | -1.94K | -38.94K | |
| PurchaseOfIntangibles | 0.00 | -1.94K | -38.94K | |
| NetPPEPurchaseAndSale | -108.11K | -444.72K | -10.79K | -415.71K |
| SaleOfPPE | 75.59K | 0.00 | ||
| PurchaseOfPPE | -183.70K | -444.72K | -10.79K | -415.71K |
| OperatingCashFlow | -2.97M | -4.76M | -6.60M | -6.03M |
| CashFlowFromContinuingOperatingActivities | -2.97M | -4.76M | -6.60M | -6.03M |
| ChangeInWorkingCapital | 1.86M | 471.70K | 1.48M | -3.61M |
| ChangeInOtherWorkingCapital | 193.59K | 286.94K | 114.79K | -3.51M |
| ChangeInOtherCurrentLiabilities | 25.87K | -141.38K | 7.03K | -53.85K |
| ChangeInOtherCurrentAssets | 4.53K | 0.00 | ||
| ChangeInPayablesAndAccruedExpense | 1.79M | 822.53K | 1.27M | 135.02K |
| ChangeInAccruedExpense | 441.44K | -102.15K | 366.13K | 20.92K |
| ChangeInInterestPayable | 166.77K | 121.86K | 1.56K | 20.92K |
| ChangeInPayable | 1.35M | 924.68K | 904.06K | 114.10K |
| ChangeInAccountPayable | 1.35M | 924.68K | 904.06K | 114.50K |
| ChangeInTaxPayable | 0.00 | -392.00 | ||
| ChangeInIncomeTaxPayable | 0.00 | -392.00 | ||
| ChangeInPrepaidAssets | -163.76K | -432.09K | 92.55K | -124.81K |
| ChangeInInventory | 44.74K | -905.00 | 24.17K | -22.40K |
| ChangeInReceivables | -34.33K | -63.40K | -26.68K | -28.77K |
| ChangesInAccountReceivables | -34.33K | -63.40K | -26.68K | -28.77K |
| OtherNonCashItems | 1.21M | 900.13K | 172.64K | 1.19M |
| StockBasedCompensation | 1.59M | 1.39M | 2.22M | 2.71M |
| AssetImpairmentCharge | 0.00 | 89.79K | 132.23K | 0.00 |
| DepreciationAmortizationDepletion | 919.60K | 200.89K | 77.30K | 166.08K |
| DepreciationAndAmortization | 919.60K | 200.89K | 77.30K | 166.08K |
| Depreciation | 306.32K | 166.08K | ||
| OperatingGainsLosses | 543.11K | 223.55K | 200.56K | 168.42K |
| EarningsLossesFromEquityInvestments | -9.04K | 60.27K | 200.56K | 327.54K |
| GainLossOnSaleOfPPE | 511.66K | 0.00 | ||
| NetIncomeFromContinuingOperations | -9.10M | -8.03M | -10.89M | -6.65M |
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
Public Trades for IVF
| Date | User | Asset | Broker | Type | Position Size | Entry Price | Patterns |
|---|